The awards program recognizes entrepreneurs who are excelling in areas such as innovation, financial performance and personal commitment to their businesses and communities. Gleeson was selected as a finalist by a panel of independent judges. Award winners will be announced at a special gala event on June 7, 2018 at the Fairmont Grand Del Mar.
Novasyte is excited to announce that Tim Gleeson, Chairman and CEO, has been selected as a semi-finalist in the Ernst & Young Entrepreneur Of The Year 2018 San Diego Regional Awards program.
This weekend marks the start of Advamed's CEO Summit here in San Diego, California, and Novayste is excited to announce our sponsorship of the event.
Bringing together many of the greatest minds and executive-level leaders in the med-tech industry, the CEO Summit facilitates engaging discussions around the global outlook and evolving trends taking place in the healthcare industry.
February marks Novasyte's 10 year company anniversary. As we reflect on where we started and how far we have come as an organization, we wanted to express thanks to every client, team member and vendor who has helped shape us as an organization.
Organizations who have previously struggled with managing a recall internally, or perhaps do not have the time or resources to maintain the consignee data, develop a field strategy or create a centralized database, can trust Novasyte as their recall management partner.
Topics: White Paper, Industry Advancements, Industry Trends, Med-Tech Industry Update, Medical Device Industry, Medical Device Recall, Medical Device Field Action, S.M.A.R.T Programs, SMART recall program
Novasyte is proud to welcome its newest member of the corporate team, Jolene Rice, who officially started in her role of Account Executive on Monday, December 11th.
Learn more about Jolene with her Q&A session below.
Novasyte LLC today announced that its Board of Directors has elected CEO Tim Gleeson, to become Chairman of the Board following Peter Gleeson, effective January 1, 2018. Tim will continue to serve as CEO while Peter will continue to serve on the Novasyte board as an independent director.
It is easy to fall into the rhythm of receiving multiple spreadsheets from various sources – be it sales, regulatory, marketing or quality – and by having them in one place, feeling like the recall is “under control.” In working with more than half of the largest med-tech companies globally, Novasyte has discovered this is a common theme.
Despite the commonality of this approach, there are inherent associated risks with managing a recall across multiple spreadsheets. Here are the top four.
Topics: White Paper, SMART recall program, S.M.A.R.T Programs, Industry Advancements, Industry Trends, Med-Tech Industry Update, Medical Device Field Action, Medical Device Recall, Medical Device Industry
Prior to launching a field team to address the product need, it is critically important to assess the effectiveness of the field strategy as it could result in a significant, potentially unnecessary, budgetary hit.
Topics: White Paper, Industry Advancements, Industry Trends, Med-Tech Industry Update, Medical Device Field Action, Medical Device Industry, Medical Device Recall, SMART recall program, S.M.A.R.T Programs
Novasyte is proud to welcome its newest member of the corporate team, Marissa Baker, who officially started in her role of Corporate Scheduler on Tuesday, November 28.
Learn more about Marissa with her Q&A session below.